Short Description

ER & PR receptor assays are routinely performed on Breast carcinoma to assess responsiveness to endocrine therapy and prognosis. Her-2 expression predicts responsiveness to Herceptin therapy. Ki-67 in addition is a useful prognositc marker. Together ER, PR, Her-2 and Ki 67 help to predict prognosis and serve as surrogate IHC markers for molecular subtypes of Breast Cancer.

PreTest Information

Provide a copy of the Histopathology report, Clinical history & indicate site of biopsy.

Detail Description

BREAST CANCER ER PR HER-2 Ki-67 cost INR:14000 symptoms diagnosis

Breast cancer is a significant health concern for women worldwide. It is essential to detect and treat it early to improve the chances of survival. DNA Labs India offers an affordable test for breast cancer diagnosis, measuring biomarkers such as ER, PR, HER-2, and Ki-67. The test costs INR 14000 and is an effective tool for early detection.

Symptoms of Breast Cancer

The following are some of the most common symptoms of breast cancer:

• A lump or thickening in the breast or armpit
• Changes in the size or shape of the breast
• Dimpling or puckering of the skin on the breast
• Nipple changes, such as inversion or discharge
• Redness or scaling on the breast or nipple
• Pain in the breast or nipple

It is important to note that not all breast lumps are cancerous, and some breast cancers may not cause any symptoms. Therefore, regular breast screenings are critical for early detection.

Diagnosis of Breast Cancer

Breast cancer diagnosis involves various tests, including:

• Physical exam and medical history
• Mammogram
• Ultrasound
• MRI
• Biopsy
• Blood tests
• Genetic testing

The DNA Labs India breast cancer test measures biomarkers such as ER, PR, HER-2, and Ki-67, providing additional information that can help guide treatment decisions. The test is non-invasive and can be performed using a blood or tissue sample.

Cost of the DNA Labs India Breast Cancer Test

The DNA Labs India breast cancer test costs INR 14000, making it an affordable option for early detection. The test measures biomarkers such as ER, PR, HER-2, and Ki-67, providing valuable information to guide treatment decisions.

Conclusion

Breast cancer is a significant health concern for women worldwide, and early detection is crucial for successful treatment. DNA Labs India offers an affordable breast cancer test that measures biomarkers such as ER, PR, HER-2, and Ki-67. The test costs INR 14000 and is a valuable tool for early detection and treatment decisions. If you have any concerns about breast cancer, talk to your healthcare provider about screening options.

For more information about the DNA Labs India breast cancer test, please visit our website or contact us today.